Antibiotics often aren’t enough to combat Clostridium difficile. But when combined with probiotics, or “good” bacteria, the results are striking. The treatment combo lessens the likelihood...
FDA responds to provider pressure, backs off stricter control of fecal transplants for C. diff
By
McKnight's Staff
Jun 19, 2013
Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for providers,...
FDA wants to fast-track treatments for C. diff
By
McKnight's Staff
Jun 13, 2013
Clostridium difficile poses a serious public health threat and potential treatments should be fast-tracked, the Food and Drug Administration stated in a newly proposed regulation.
Depression tied to C. diff
By
Tim Mullaney
Jun 01, 2013
Depressed or lonely people are at increased risk of Clostridium difficile infection, according to research in BMC Medicine.
Catching bad bugs
By
John Andrews
Jun 01, 2013
New strains of drug-resistant pathogens are targets of more scrutiny among infection control professionals employed in long-term care environments.
Probiotics reduce risk of C. diff symptoms by 64%, researchers say
By
McKnight's Staff
Jun 03, 2013
Long-term care facilities dealing with an outbreak of Clostridium difficile have a good chance of reducing symptoms of the infection by administering probiotics, according to a recently released comprehensive...
Fecal transplants to treat C. diff now need FDA approval
By
McKnight's Staff
May 17, 2013
The Food and Drug Administration is moving to tighten regulations around fecal transplants, which research has shown to be an effective treatment for Clostridium difficile infection.
Depressed, lonely seniors are more likely to get C. diff, researchers find
By
McKnight's Staff
May 09, 2013
People who are depressed or lonely are at increased risk of Clostridium difficile infection, according to recently published research.
Stomach acid drugs raise risk of C. diff
By
Elizabeth Newman
May 01, 2013
Stomach acid is often treated with medications such as Pepcid, but that could put long-term care residents or hospitalized patients at risk for Clostridium difficile, according to a new analysis.
CompanyBriefs
May 01, 2013
Pfizer must pay $142 million for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a federal appeals court has ruled. The justices refused to overturn a jury’s previous...